Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound® (tirzepatide) to include the four-dose single-patient use KwikPen® that ...
Dr. Donian Shen of Serenity Sleep Solutions attended IAOS SleepCon 2026 to engage in continuing education focused on ...
A retrospective cohort study suggested that SARS-CoV-2 infection was associated with a modest risk of developing obstructive ...
Children with pediatric obstructive sleep apnea had higher influenza and COVID-19 diagnoses over five years in a large matched cohort.
Sleep Apnea is a serious disorder that causes poor oxygen flow to the body, and if left untreated, raises risks for ...
AIOMEGA® announced the first prescribed clinical use of AIO BREATHE® mandibular repositioning device, FDA-cleared for ...
Researchers have found in a new study that insomnia or obstructive sleep apnea (OSA) during pregnancy may be associated with ...
Around 30 million adults in the US have obstructive sleep apnea (OSA) and about 80% of them are undiagnosed. That means ...
Growth is driven by rising disposable incomes, wellness trends, and demand for personalized solutions. Major players innovate ...
Obstructive sleep apnea (OSA) affects almost 1 billion adults worldwide and carries substantial healthcare and productivity costs.
Incannex Healthcare Inc. (NASDAQ: IXHL): Stonegate Capital Partners updates their coverage on Incannex Healthcare Inc. (NASDAQ: IXHL). Incannex continued to build the clinical and patient-reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results